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SUMMARY
Mouseandhumandendritic cells (DCs) arecomposed
of functionally specialized subsets, but precise inter-
species correlation is currently incomplete. Here, we
showed that murine lung and gut lamina propria
CD11b+ DC populations were comprised of two sub-
sets: FLT3- and IRF4-dependent CD24+CD64! DCs
and contaminating CSF-1R-dependent CD24!CD64+
macrophages. Functionally, loss of CD24+CD11b+
DCs abrogated CD4+ T cell-mediated interleukin-17
(IL-17)production insteadystateandafterAspergillus
fumigatus challenge. Human CD1c+ DCs, the equiva-
lent of murine CD24+CD11b+ DCs, also expressed
IRF4, secreted IL-23, and promoted T helper 17 cell
responses. Our data revealed heterogeneity in the
mouse CD11b+ DC compartment and identifed
mucosal tissues IRF4-expressing DCs specialized
in instructing IL-17 responses in both mouse and
human. The demonstration of mouse and human DC
subsets specialized in driving IL-17 responses high-
lights the conservation of key immune functions
across species and will facilitate the translation of
mouse in vivo findings to advance DC-based clinical
therapies.
INTRODUCTION
Dendritic cells (DCs) initiate and regulate immune responses
against pathogens and maintain tolerance to self-antigens
(Banchereau et al., 2000; Steinman et al., 2003) and as such are
potential targets of immunotherapeutic interventions (Palucka
et al., 2010). DCs are heterogeneous and can be subdivided by
anatomical location, origin, and function. DCs are found in
lymphoid and nonlymphoid tissues (NLT). In mice, lymphoid
tissue (LT) DCs are categorized into two groups: plasmacytoid
DCs (pDCs) and classical DCs, and the latter include CD8+
CD4–CD11b– (CD8+ DC), CD8–CD4+CD11b+ (CD4+CD11b+ DC),
and CD8–CD4–CD11b+ DC populations (Shortman and Naik,
2007). In peripheral NLTs, DCs that populate the outer epidermal
layer of stratified epithelia are termed Langerhans cells, whereas
DCs in connective tissues are called interstitial DCs. The inter-
stitial DC populations are distinguished by mutually exclusive
surface expression of the integrins CD103 and CD11b in steady
state (Ginhoux et al., 2009). In the gut lamina propria (LP), an
additional subset expressing both CD103 and CD11b has been
described (Annacker et al., 2005; Bogunovic et al., 2009).
Recent studies on DC differentiation and function have
highlighted many parallels between LT and NLT DC populations,
in particular between CD8+ and CD103+ DCs (for review, see
Hashimoto et al., 2011). The NLT CD103+ DCs and CD8+ LT resi-
dent DCs constitute an independent DC lineage; both reliant
upon the Fms-like tyrosine kinase 3 ligand receptor (FLT3) and
the transcription factors (TFs) IRF8, ID2, and BATF3. Both
populations are endowed with superior ability to cross-present
viral, tumor, and self-antigens. We recently showed that a
functionally-equivalent cross-presenting DC lineage is con-
served in human peripheral tissues identifying the CD141hi DC
subset with substantial cross-presenting capacities (Haniffa
et al., 2012), similar to blood CD141+ DCs (Bachem et al.,
2010; Crozat et al., 2010; Poulin et al., 2010). By using inter-
species transcriptomic analysis, we demonstrated homology
between human CD141+ DC lineage with mouse NLT CD103+
and CD8+ splenic DCs (Haniffa et al., 2012), as previously
suggested for blood CD141+ DCs (Crozat et al., 2010).
In contrast, the relationships between NLT and LT CD11b+ DC
populations and their unique immune specializations remain
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unclear. Several TFs controlling splenicCD11b+DCdevelopment
have been identified and include IRF2, IRF4, IKAROS, RELB, and
the members of the Notch pathway, NOTCH2 and RBP/J (for
review, see Hashimoto et al., 2011). Recent data have revealed
that the gut LP CD103+CD11b+ DC also rely on NOTCH2 (Lewis
et al., 2011), but the dependency of other NLT CD11b+ DCs on
these TFs remains to be defined. In addition, NLT and LT
CD11b+ DCs appear to be heterogeneous in both origin and dif-
ferentiation. NLT CD11b+ DCs can be derived from both bone
marrow (BM) DC specific progenitors and monocytes in steady
state (Ginhoux et al., 2009) and are partially dependent on both
FLT3 and the colony-stimulating factor 1 receptor (CSF-1R)
(Ginhoux et al., 2009). This is corroborated by the demonstration
of heterogeneity within murine splenic CD8!CD11b+ DCs, which
are composed of endothelial cell-selective adhesion molecule
(ESAM)+CD4+ and ESAM!CD4! fractions, the latter suggested
as being monocyte-derived (Lewis et al., 2011).
Our recent analysis to define homologies between mouse and
human DCs also predicted the existence of monocyte and/or
macrophage cells within NLT CD11b+ DC population (Haniffa
et al., 2012). Human peripheral tissueDCs are composed of three
main subsets in the steady state: CD141hi DCs, equivalent to the
CD8/CD103murine lineage; CD14+DCs, related to themonocyte
and/or macrophage lineage; and CD1c+ DCs (Haniffa et al.,
2012).HumanCD1c+DCswerepositively associatedwithmurine
splenic CD4+ DCs but not tissue CD11b+ DCs. Surprisingly,
humanCD14+DCswerepositively associatedwithmurinemono-
cytes andNLTCD11b+DCs, suggesting contaminationbymono-
cyte-macrophage cells within the NLT CD11b+ DC fraction.
We therefore hypothesized the existence of a specialized DC
subset within the NLT CD11b+ fraction with defined TF depen-
dence and function that is conserved between mouse and
human.Here,we identify FLT3-dependentCD11b+CD24+CD64!
bona fide DCs and CSF-1R-dependent CD11b+CD24!CD64+
macrophages in steady state within MHC class II (MHCII)+
CD11c+CD11b+ cells in the lung and small intestine (SI). Mucosal
CD24+CD11b+ DCs were dependent on IRF4 and secreted the T
helper 17 (Th17) cell prone cytokine interleukin-23 (IL-23),
instructing Th17 cell differentiation in steady state and after
Aspergillus fumigatus (A. fumigatus) challenge. We also showed
that human CD1c+ DCs express IRF4, secrete IL-23, and are the
functional homologs ofmurine tissueCD11b+CD24+CD64!DCs.
RESULTS
Lung CD11b+ DCs Are Heterogeneous
We first sought to identify specific markers that could discrimi-
nate bona fide DCs from monocyte-macrophage cells within
tissue CD11b+MHCII+CD11c+ fraction. Lung SSCloMHCII+
CD11c+CD11b+ fraction contained two distinct populations
distinguished by the expression of the sialoglycoprotein CD24
(heat-stable protein) and CD64 (FcgR1) (Figure 1A; see also Fig-
ure S1A available online). CD24+CD64!CD11b+ cells were char-
acterized by their expression of the DC markers CD11c, BTLA,
and CD26 (Miller et al., 2012), while CD24-CD64+CD11b+ cells
were characterized by their expression of the monocyte/macro-
phage markers CD14, the fractalkine receptor CX3CR1, and
lysozyme (Figure 1B). Migratory CD11b+ DCs in the lung draining
lymph nodes (LLN) expressed high amounts of CD24 and no
CD64, suggesting that only CD11b+CD24+CD64! cells migrate
to LLN (Figure 1C). Morphologically, CD24+CD64!CD11b+ cells
exhibited fine dendrites and large cytoplasms characteristic of
DCs, whereas CD24!CD64+CD11b+ cells were a mixture of
larger cells with vacuoles and membrane ruffles alongside small
monocyte-like cells with smooth membranes (Figure 1D).
Tissue DCs proliferate in situ in the steady state (4%–6% in
S-G2-M phase), whereas macrophages (MACs) are more quies-
cent (1%–2% in S-G2-M phase) (Ginhoux et al., 2009; Liu et al.,
2009). By using Fucci-492 mice where cells in S, G2, and M
phases of the cell cycle are fluorescent (Sakaue-Sawano et al.,
2008), we observed that 5%–7% of lung CD103+ DCs and
CD11b+CD24+ cells were in active cell cycle compared to 3%
of CD11b+CD24! cells (Figure 1E). These results demonstrate
the presence of two distinct populations in the steady state
within the MHCII+CD11c+CD11b+ fraction; (1) a CD24+CD64!
CD11b+ cell expressing DC-related antigens and higher prolifer-
ative status and (2) a CD24!CD64+CD11b+ cell expressing
macrophage markers with low cell-cycle activity.
Lung CD11b+CD24+CD64– Cells Are Bona Fide DCs,
whereas CD11b+CD24–CD64+ Cells Are Macrophages
Wehypothesized that CD24+CD64!CD11b+ cells represent bona
fide lung DCs (named thereafter CD11b+ DCs), whereas
CD24!CD64+CD11b+ cells correspond to interstitial macro-
phages (named thereafter CD11b+ MACs), known to express
high amounts of MHCII (Bedoret et al., 2009). We investigated
the dependency of CD11b+ DCs and CD11b+ MACs on the DC
differentiation cytokine receptor FLT3 and the monocyte-macro-
phage differentiation cytokine receptor CSF-1R. Flt3 messenger
RNA (mRNA) expressionwas highest on purifiedCD103+DCs fol-
lowed by CD11b+ DCs and at an extremely low level on CD11b+
MACs (Figure 2A; see Figure S1A for sorting strategy). In contrast,
CD11b+ MACs had the highest expression of Csf-1r. We then
tested their requirement for functional expression of FLT3 and
CSF-1Rby usingmixedBMchimeras (Figures 2B–2G; Figure S2).
Consistent with our previous report (Ginhoux et al., 2009), the
ability of Flt3!/! BM progenitors to generate lung and LLN
CD103+ DCs was dramatically reduced (Figures 2B and 2D).
Flt3!/! BM progenitors were also less efficient at generating
lung and LLN CD11b+ DCs (Figure 2B and 2D) at a similar level
to splenic DC subsets, regardless of ESAM expression within
CD11b+ DCs (Figure 2F). In contrast, Flt3!/! BMprogenitors fully
reconstituted the CD11b+ MAC population, suggesting its inde-
pendence of FLT3 signaling. Csf-1r!/! progenitors efficiently
generated CD103+ and CD11b+ DC subsets in the lung and LLN
(Figures 2C and 2E), but not CD11b+ MACs (Figure 2C). Further-
more,Csf-1r deficiency did not affect any splenic DC subset (Fig-
ure 2G). We also tested the ex vivo ability of these different lung
DC and MAC populations to present intratracheally delivered
ovalbumin (OVA) to OTII-Rag1!/! CD4+ T cells recognizing the
I-Ab restricted OVA323–339 peptide (Barnden et al., 1998). As ex-
pected,CD11b+DCs inducedgreatestOTII proliferation,whereas
theCD11b+MACswere poor stimulators of OTII cells (Figure 2H).
Lung CD11b+ DCs Are Dependent on IRF4
We next analyzed the expression of cytokine receptors and TFs
known to be important for DC andmacrophage differentiation by
CD11b+ DCs and CD11b+ MACs (Table S1). By using microarray
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analysis, we identified genes that were differentially expressed
by splenic CD8+ and lung CD103+ DCs compared to splenic
CD11b+CD4+DCs. Hierarchical clustering based on the differen-
tially expressed genes showed that lung CD11b+ DCs clustered
Figure 1. Lung CD11b+ DCs Are Heteroge-
neous
(A) Flow cytometry of mouse lung cell suspen-
sion. Gating strategy to identify CD103+ DCs
(green gate), CD11b+CD24+ DCs (blue gate), and
CD11b+CD64+ MACs (red gate) is shown.
(B and C) Histograms show relative expression of
the indicated markers on lung DCs and MACs (B).
Flow cytometry of mouse LLN cell suspension.
Gating strategy as described in (A) was used in (C).
Representative data from n > 5 shown for (A)–(C).
(D) Morphology of purified lung DCs and MACs
visualized by GIEMSA staining and SEM.
(E) Percentage proliferation of lung DCs and MACs
indicated by fluorescence levels in Fucci mice
(mean fluorescent+ cells ± SEM, pooled results of
three experiments, n = 6). See also Figure S1.
with splenic CD4+ DCs, whereas CD11b+
MACs were distantly related (Figure 3A),
suggesting a similar developmental pro-
gram between lung CD11b+ DCs and
splenic CD11b+CD4+ DCs.
Microarray data showed highest
expression of Irf4 on lung CD11b+ DCs
(Figure 3A). Q-PCR (Figure 3B) and flow
cytometric (Figure 3C) analyses confirmed
that lung CD11b+ DCs expressed higher
amounts of IRF4 than either lung CD103+
DCs or CD11b+ MACs. Because IRF4
is known to regulate splenic CD4+ DC dif-
ferentiation (Suzuki et al., 2004; Tamura
et al., 2005), we tested whether lung
CD11b+ DC differentiation was affected
by IRF4 deficiency by using mixed BM
chimeras. Lung CD11b+ DCs were
adversely affected by IRF4 deficiency but
CD103+ DCs and CD11b+ MACs were
unaffected (Figure 3D). This defect was
more dramatic in the LLN (Figure 3E).
However, we did not detect any defects
in the splenic CD11b+ DC population (Fig-
ure 3F), regardless of ESAM expression
that correlates with CD4+ DCs (Lewis
et al., 2011).
Small Intestinal LP
CD24+CD103+CD11b+ DCs Are Also
Dependent on IRF4
We extended our analysis to other NLTs
(dermis, kidney, liver, and gut) to test
whether similar CD11b+CD24+CD64!
DCs were present in these organs. Only
gut LP CD11b+ DCs in the small and large
intestine segregated clearly into CD24+
CD64! and CD24!CD64+ populations (Figure 4A; Figures S1B
and S3A), whereas CD24 and CD64 were not fully discrimina-
tory in the dermis, kidney, or liver (data not shown). Further-
more, there was no correlation between IRF4 and CD24
Immunity
IRF4-Dependent DCs Control Mucosal IL-17 Responses
972 Immunity 38, 970–983, May 23, 2013 ª2013 Elsevier Inc.
expression in these organs detectable by flow cytometry (data
not shown).
The small intestinal LP (SI-LP) CD11b+ DC fraction contained a
CD24+CD64! DC population (CD11b+ DCs) and CD24!CD64+
macrophages (CD11b+ MACs). However, unlike lung CD11b+
DCs, the SI-LP CD11b+ DCs were mostly CD103+ (CD11b+
CD103+ DCs), with a minor CD103! fraction (CD11b+CD103!
DCs) (Figure 4A), as previously described (Annacker et al., 2005;
Bogunovic et al., 2009; Cerovic et al., 2012). CD11c expression,
but not CD26 or BTLA, discriminated CD11b+ DCs (regardless
of CD103 expression) from CD11b+ MACs (Figure S3B). In
contrast, SI-LP CD11b+ MACs expressed higher amounts of the
Figure 2. Lung CD11b+CD24+CD64– Cells
Are Bona Fide DCs, whereas CD11b+CD24–
CD64+ Cells Are Macrophages
(A) Relative expression of Flt3 and Csf-1r mRNA by
lung DCs and MACs (n = 3, mean ± SEM).
(B–G) Percentage of CD45.2 and CD45.1 DCs and
MACs in the indicated tissues from mixed BM
chimeric mice (CD45.2 WT: CD45.1 WT; CD45.2
Flt3!/!: CD45.1 WT (B, D, F); CD45.2 Csf1r!/!:
CD45.1 WT (C, E, G).
(H) Bar graph shows mean ± SEM of the indicated
cell populations (pooled results of four experi-
ments, n = 12). Percentage proliferation of OTII
cells stimulated by OVA-loaded lung DCs and
MACs (n = 3, mean ± SEM). See also Figure S2.
monocyte-macrophage markers CD14,
CX3CR1, and lysozyme (Figure S3B).
Similar to LLN, the CD11b+ fraction of
migratory DCs (CD11cloMHCIIhi) in the
mesenteric lymphnodes (MLN) expressed
CD24 and not CD64, suggesting that
only the CD11b+CD24+CD64! fraction
migrates toMLN (Figure 4B), as previously
reported (Bogunovic et al., 2009; Schulz
et al., 2009). Mixed BM chimera experi-
ments showed that both LP CD11b+
CD103+ DCs and CD24+CD103+ DCs
were FLT3 dependent and CSF-1R inde-
pendent, whereas CD11b+ MACs were
CSF-1R dependent (Figures 4C and 4D).
LP CD11b+CD103! DCs were CSF-1R
and FLT3 independent because their
chimerism was similar to blood gran-
ulocytes used as engraftment control
(Figure S2).
We also tested whether SI-LP CD11b+
DCs (regardless of CD103 expression)
were dependent on IRF4. SI-LP CD11b+
CD103! DCs expressed lower levels of
IRF4 (Figure 4E) and were independent
of IRF4, as were CD11b!CD103+ DC
and CD11b+ MAC populations (Figures
4F and 4G). In contrast, LP CD11b+
CD103+ DCs expressed the highest level
of IRF4 (Figure 4E) and were partially
dependent on IRF4 expression (Fig-
ure 4F). Their relationship with LP CD11b+CD103! DCs remains
to be investigated. Furthermore, correlating with the lung data,
migratory MLN CD11b+CD103+ DCs were also entirely depen-
dent on IRF4 (Figure 4G). Analogous CD24+CD11b+ DCs,
CD64+CD11b+ MACs, or an IRF4-dependent population was
undetectable in the dermis, kidney, and liver (data not shown).
Lung CD11b+ DCs and Small Intestinal LP
CD11b+CD103+ DCs Are Absent in Mice Lacking
IRF4 in the DC Lineage
We next established whether the lung and SI-LP IRF4-
dependent DC subsets shared functional specializations. We
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crossed the DC-specific Cre recombinase mouse (Itgax-cre)
(Caton et al., 2007) with a mouse wherein the Irf4 gene (exons
1 and 2) is flanked by loxP sites and a GFP construct is placed
in the reverse orientation, upstream of the Irf4 promoter region
(Irf4fl/fl) (Klein et al., 2006). In these mice (Itgax-cre Irf4fl/fl),
expression of the Cre recombinase leads to excision of both
exons, preventing transcription of the Irf4 gene only in
CD11c+ cells and concomitantly enabling GFP expression in re-
combined CD11c+ cells, allowing the tracking of Irf4-deficient
cells (Klein et al., 2006). As expected, CD11c+MHCII+ DCs
were GFP+ in all tissues tested (Figures S4A–S4C). Other pop-
ulations expressing GFP were Gr1lo monocytes (80%), CD3+
T cells (25%), and B220+CD19+ B cells (15%) (Figure S4D).
Mice exhibiting >25% GFP+ lymphocytes were excluded from
our studies.
Absence of IRF4 expression in DCs led to a specific depletion
of CD24+CD11b+ DCs in the lung and LLN and CD24+ CD11b+
CD103+ DCs in the gut LP and MLN (Figures S4E–S4J). Other
DC and MAC populations were unaffected, despite expressing
similar levels of GFP (Figure S4). Similar to the data obtained
from mixed BM chimeras, we did not detect any defects in DC
populations in the dermis or liver but observed a slight decrease
in the kidney CD11b+CD24+ DC fraction (Figures S4K–S4O).
We next investigated how IRF4 regulates mucosal tissue
CD11b+ DC homeostasis. To examine whether IRF4 con-
trolled CD11b+ DC homeostasis at the progenitor level, we quan-
tified CD11c+ DC progenitors including pre-DCs (Liu et al., 2009)
and CCR9! pre-pDCs (Schlitzer et al., 2012) in Itgax-cre Irf4fl/fl
versus control littermate (wild-type, WT) BM. Both DC progeni-
tors were GFP+ as a mark of IRF4 excision in Itgax-cre Irf4fl/fl
(Figure S5A). We found no differences in their relative numbers
(Figure S5B). We next tested whether IRF4 was playing a prosur-
vival role in CD11b+ DC homeostasis, a considerably difficult
experiment to perform as very few CD11b+ DCs remained in
the Itgax-cre Irf4fl/fl mice. As such, only the lung yielded enough
cells for analysis. Because cells undergoing apoptosis show
enhanced mitochondrial fission and fragmentation (Martinou
and Youle, 2011), we performed a mitotracker assay that as-
sessed mitochondrial network integrity in lung CD11b+ DCs
lacking IRF4. The remaining lung CD11b+ DCs in Itgax-cre Irf4fl/fl
mice showed significantly enhanced mitochondrial frag-
mentation, as observed during apoptosis, compared to WT
mice (Figures S5C and S5D). These data suggest that IRF4 has
a prosurvival role and its absence in mucosal tissue CD11b+
DCs leads to apoptosis, likely explaining the depletion of
mucosal tissue CD11b+ DCs in Itgax-cre Irf4fl/fl mice.
Figure 3. Lung CD11b+ DCs Are IRF4 Dependent
(A) Hierarchical clustering of murine spleen and lung DC/MAC populations based on differential expression of selected genes (SAM algorithm, delta = 2.6).
(B) Irf4 mRNA expression by lung DCs and MACs (n = 3, mean).
(C) Relative expression of IRF4 by flow cytometry on lung CD11b+ DCs and MACs (n = 3).
(D–F) Percentage of CD45.2 and CD45.1 DCs and MACs in the indicated tissues from indicated mixed BM chimeric mice. Bar graphs show mean ± SEM of the
indicated cell populations (pooled results of four experiments, n = 10, mean ± SEM). See also Figure S2 and Table S1.
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IRF4-Dependent CD24+CD11b+ DCs Control Th17
Responses in Steady State
The loss of LP CD11b+CD103+ DCs, which correspond to our
IRF4-dependent CD24+CD64!CD11b+CD103+ DC subset, is
associated with reduced IL-17-producing CD4+ T cells in the
intestine (Lewis et al., 2011). We also observed that CD11b+
DCs expressed Th17 cell-polarizing molecules, such as
IL-23p19, IL-6, and TGF-b in our microarray data (Figure 5A).
We quantified IL-23p19 mRNA expression from unstimulated
sorted tissue DC and MAC populations (for sorting strategy,
see Figure S1) and confirmed that lung CD11b+ DCs and SI-LP
CD11b+CD103+ DCs homeostatically expressed IL-23p19,
Figure 4. Gut Lamina Propria CD24+CD103+
CD11b+ DCs Are Dependent on IRF4
(A) Flow cytometry of gut LP to identify CD103+
DCs, CD103+CD11b+ DCs, CD103-CD11b+ DCs,
and CD11b+ MACs (n = 5).
(B) Flow cytometry of MLN to identify DCs and
MACs as described in (A), (n = 5).
(C, D, F, and G) Percentage of CD45.2 and CD45.1
DCs and MACs in the indicated tissues from
indicated BM chimeric mice.
(E) Pooled results from four experiments, n = 10
(mean ± SEM). IRF4 expression on SI-LP DCs
and MACs by flow cytometry (n = 3). See also
Figure S3.
IL-6, TGF-b, and IL-1, but not IL-10 and
only minute amounts of IL-12 mRNA
(Figures 5B–5D), underlining the func-
tional homology between these two sub-
sets. We quantified the proportion of
CD3+CD4+ T cells expressing interferon-g
(IFN-g) or IL-17A in the lung and SI-LP of
WT compared to Itgax-cre Irf4fl/fl by intra-
cellular cytokine staining. As expected
(Lewis et al., 2011), in Itgax-cre Irf4fl/fl
mucosal tissues, the proportion of Th17
cells was reduced in steady state com-
pared to WT, whereas Th1 cells were
concomitantly increased (Figure 5E;
Figure S5E).
IRF4-Dependent CD24+CD11b+
Lung DCs Control Th17 Cell
Responses
Next, we assessed the functional conse-
quences of the absence of lung CD11b+
DCs in an infection model dependent on
Th17 cell responses such as the fungal
pathogen A. fumigatus, a prevalent envi-
ronmental fungus that causes potentially
lethal infections in immunosuppressed in-
dividuals (Hohl and Feldmesser, 2007;
Romani, 2004).
We first infected WT and Itgax-cre
Irf4fl/fl mice with a sublethal dose of live
A. fumigatus conidia and monitored
IFN-g and IL-17A production by
CD3+CD4+ T cells on day 7 of infection. Itgax-cre Irf4fl/fl mice
exhibited decreased effector Th17 T cell responses compared
to WT in the lung (Figure 5F). However, to determine whether
this decreased Th17 cell response was specifically due to the
absence of lung CD11b+ DCs, we performed a similar ex-
periment in a mouse model (langerin-DTR) in which the
CD11b!CD103+ DCs can be selectively ablated upon Diphtheria
toxin (DT) administration (GeurtsvanKessel et al., 2008). There
was no reduction in Th17 cell responses in CD103+ DC-depleted
compared to CD103+ DC-sufficient mice (Figure S5F). Fungal
burdens were assessed by quantitative culture of fungal
colony-forming units (CFU) from homogenized infected lungs
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Figure 5. CD11b+CD24+ DCs in Lung and SI Control Th17 Responses
(A–D) Expression of indicated genes in lung DCs andMACs bymicroarray (A), by Q-PCR in lung (B), and Q-PCR and nanostring in SI-LP (C and D) DCs andMACs
(mean ± SEM, n = 3).
(E) Percentage of IL-17A and IFN-g expressing CD3+CD4+ T cells in steady state from lung, lymph node, SI-LP, and MLN of WT (white bars) and Itgax-cre Irf4fl/fl
(black bars) mice (mean ± SEM, pooled results of two experiments, n = 10). (F) Same as (E) after A. fumigatus challenge.
(F) Representative dot plot shown left and bar graphs show composite data (mean ± SEM, pooled results of four experiments, n = 20).
(legend continued on next page)
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of WT, Itgax-cre Irf4fl/fl, and langerin-DTR mice (Figures 5G and
5H). As expected from the altered Th17 T cell response in
Itgax-cre Irf4fl/fl, the fungal burdens were significantly higher in
these mice (Figure 5G), although without associated mortality.
In contrast, in line with the unchanged Th17 T cell response in
DT treated langerin-DTR, the fungal burdens were similar to con-
trol levels (Figure 5H). These data identify an IRF4-dependent
CD11b+CD24+CD64! DC population in mucosal tissues with
functional specialization to instruct IL-17 responses during
steady state and infection.
Transcriptomic Alignment of Mouse IRF4-Dependent
CD11b+ DCs with Human CD1c+ DCs
To address the putative relationship between mouse CD11b+
DCs and human CD1c+ DCs, we first identified the differentially
expressed genes (DEG) between mouse lung CD11b+ DCs and
CD11b+ MACs and then identified their human orthologs as
described in the Experimental Procedures section. Given the
logistical difficulties of obtaining sufficient material to perform
microarray analysis on human lung DCs, we used microarray
data of equivalent cells in human blood. We previously showed
that CD14+ monocytes were positively associated with intersti-
tial CD14+ DCs (Haniffa et al., 2012) and also cluster with intersti-
tial MACs (data not shown). We predicted that DEG between
CD11b+ DCs and CD11b+ MACs would correspond to DEG
between human blood CD1c+ DCs and CD14+ monocytes.
Therefore, we identified the DEG between human blood CD1c+
DCs and CD14+ monocytes (Figure 6A; Tables S2 and S3) and
compared them between species. Forty-three genes were
commonly differentially expressed in both mouse CD11b+ DCs
and blood CD1c+ DCs compared to CD11b+ MACs and CD14+
monocytes, respectively (p = 2.32e!18) (Figure 6B) and include
Irf4, Ccr7, and the cell-cycle genes Cdh1 and Cdca71 (Figures
6C and 6D). Fifty-nine genes were commonly differentially
expressed in both mouse CD11b+ MACs and CD14+ monocytes
compared to CD11b+ DCs and blood CD1c+ DCs respectively
(p = 4.46e!33) (Figure 6B). The reverse approach identified only
14 genes commonly differentially expressed in both mouse
CD11b+ DCs and blood CD14+ monocytes compared to
CD11b+ MACs and CD1c+ DCs, respectively (p = 0.046) (data
not shown). The higher enrichment of common DEG between
mouse CD11b+ DCs and human CD1c+ DCs compared to
CD11b+ DCs and CD14+ monocytes implies homology between
human CD1c+ DCs and murine CD11b+ DCs.
Human IRF4-Expressing CD1c+ DCs Induce IL-17 T
Helper Responses following A. fumigatus Challenge
Phenotypic analysis of human blood and lung DC subsets for DC
and macrophage antigens showed similar expression profile for
CD11b, CD64, CD11c, and CX3CR1 on blood and lung CD1c+
DCs relative to their respective tissue CD141+ DCs and CD14+
monocyte or DCs. Both human lung CD1c+ DC and murine
CD11b+ DCs are CD11b+, CD14!, CD11c+, BTLA+, and
CX3CR1+ (Figures 7A and 7B; Figure S6A). We next tested
whether human CD1c+ DCs expressed IRF4 protein, in line
with our microarray data and the IRF4-dependent nature of
murine tissue CD11b+ DCs. We assessed intracellular IRF4
expression on blood, lung, and SI DC subsets by flow cytometry
and observed highest IRF4 expression on CD1c+ DCs from all
three tissues (Figure 7C). Because human Th17 cell responses
to pathogens including A. fumigatus have been documented
(Chamilos et al., 2010; Sallusto et al., 2012), we assessed
whether CD1c+ DCs were capable of inducing Th17 cell re-
sponses following A. fumigatus challenge. Unstimulated lung
CD1c+ DCs expressed higher levels of the Th17 cell polarization
cytokine IL-23p19 transcript compared to CD141+ DCs but at a
comparable level to CD14+ DCs (Figure 7D). We also measured
cytokine secretion by blood CD1c+ DCs and CD14+ monocytes
in response to a range of stimuli (Figure S6B). Blood CD1c+ DCs
consistently produced higher amounts of IL-23p19 upon stimu-
lation with CD40L+LPS, the TLR3 agonist poly I:C and the
TLR7-8 agonist CL075 in addition to A. fumigatus hyphae stimu-
lation. IL-12p70 was detected only upon stimulation of CD1c+
DCs with CL075 but at a lower concentration to IL-23p19 by
using the same stimulus.
In order to assess Th17 cell induction by human DCs, we
cultured A. fumigatus hyphae stimulated lung and blood DC sub-
sets with autologous CD4+ T cells and assessed T cell IL-17A
and IFN-g production. Both lung and blood CD1c+ DCs were
potent inducers of CD4+ T cell IL-17A production compared to
CD141+ DCs and CD14+ DC and/or monocytes (Figure 7E; Fig-
ures S6C and S6D), demonstrating conserved interspecies
IRF4-expressing DC function in relation to IL-17 immune re-
sponses following A. fumigatus challenge.
DISCUSSION
This study describes the phenotype and function of human and
murine IRF4+CD11b+ DCs found in mucosal tissues that control
Th17 T cell differentiation through the secretion of IL-23 during
steady state and inflammation. We have identified FLT3-depen-
dent CD11b+CD24+CD64! bona fide DCs and CSF-1R-depen-
dent CD11b+CD24!CD64+ MACs in steady state lung and SI.
The separation of these two cell types clarifies previous sugges-
tions of heterogeneity within tissue MHCII+CD11c+CD11b+ cells
(Ginhoux et al., 2009). Supporting these data, the DC lineage-
restricted TF Zbtb46 is highly expressed in the CD24+ fraction
of lung MHCII+CD11c+CD11b+ and gut LP MHCII+CD11c+
CD11b+CD103+ populations (Satpathy et al., 2012). Similarly,
CD64, a recognized marker of human macrophages, was
recently shown to identify murine macrophages (Gautier et al.,
2012; Tamoutounour et al., 2012) and inflammatory lung (Plan-
tinga et al., 2013) and muscle (Langlet et al., 2012) DCs. Gautier
et al. also highlighted heterogeneity within lung CD11b+
DCs, describing CD24+CD64! cells potentially as DCs and
CD24!CD64+ cells as macrophages (Gautier et al., 2012). We
(G) CFUs from homogenized lung tissue of either WT (white bars) or Itgax-cre Irf4fl/fl (black bars) mice 7 days after intranasal infection with A. fumigatus (mean ±
SEM, pooled results of four experiments, n = 20).
(H) Same than (F) with Langerin-DTR mice (white bars) or Langerin-DTR mice injected with DT (black bars) (mean ± SEM, pooled results of two experiments,
n = 10). See also Figures S4 and S5.
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Figure 6. Transcriptomic Alignment of Mouse IRF4-Dependent CD11b+ DCs with Human CD1c+ DCs
(A) Scatterplot of mouse CD11b+ DCs versus CD11b+ MACs and human CD1c+ DCs and CD14+ monocytes. Common DEG for mouse CD11b+ DCs and human
CD1c+ DCs are highlighted in red, whereas common DEG for mouse CD11b+ MACs and CD14+ monocytes are highlighted in green. All genes depicted are
regulated < 1.5-fold.
(B) Analysis strategy depicting the number of DEG, which are shared and not shared between mouse CD11b+ DCs, mouse CD11b+ MACs, human CD1c+ DCs,
and human CD14+ monocytes.
(C) Heatmap showing expression in CD14+ monocytes and CD1c+ DCs of common DEG identified between mouse CD11b+ DCs and human CD1c+ DCs.
(D) Same than (C) with mouse CD11b+ DCs and CD11b+ MACs. See also Figure S7 and Tables S2 and S3.
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now propose a general gating strategy for analyzing the CD11b+
DCs in gut and lung, which will remove contaminating MHCII+
macrophages.
Investigating the parallel between NLT and LT DCs, we found
that gut CD24+CD11b+CD103+ DCs and lung CD24+CD11b+
DCs expressed IRF4, similar to splenic CD4+CD11b+ DCs.
However, unlike splenic CD4+CD11b+ DCs, both NLT DC popu-
lations were dependent on IRF4 as shown by the decreased
contribution of the IRF4-deficient BM cells to these populations
in mixed BM chimeras and their dramatic reduction in mice lack-
ing IRF4 expression in the DC lineage. Importantly, DC specific
IRF4 deficiency did not fully ablate lung or gut CD24+CD11b+
DCs, suggesting that IRF4 is not involved in their differentiation
but rather in their survival or proliferation. In agreement with
this hypothesis, we found no differences in the relative numbers
Figure 7. Human IRF4 Expressing CD1c+
DCs Induce IL-17 T Helper Response
Flow cytometry of peripheral blood and mechani-
cally dispersed lung. Gating strategy used to
identify three myeloid DC subsets within Lin!HLA-
DR+ fraction (CD123+ pDCs were excluded from
the CD14!CD16! fraction): (1) CD14+ monocytes
(red gate), (2) CD14!CD1c+CD141! DCs (blue
gate), (3) CD14!CD1c!CD141+ DCs (green gate).
(A) Representative from ten blood and three lung
donors are shown. Relative expression of indi-
cated markers by CD14+ monocytes/DCs (red),
CD1c+ DCs (blue), and CD141+ DCs (green).
(B) Representative data from three blood and lung
donors are shown.
(C) Same as (B) for IRF4 expression compared to
isotype (black) from indicated tissues. Represen-
tative data from three blood, lung, and two SI
donors are shown. mRNA expression of IL-23p19
by freshly sorted human DC subsets from lung (n =
3, mean ± SEM).
(D) Expression normalized to IL-23p19 mRNA
expression in unstimulated CD141+ DCs. Intra-
cellular IFN-g and IL-17A expression by PMA/
Ionomycin restimulated CD4+ T cells cultured with
autologous lung indicated DC subsets pulsed with
A. fumigatus hyphae.
(E) Representative dot plot with percentage of
total IL-17+ cells and composite results shown in
bar graph (n = 4, mean ± SEM fold increase
[%+DC/%-DC]).
of DC progenitors in Itgax-cre Irf4fl/fl
versus WT mice suggesting that IRF4
involvement is not at the DC progenitor
level. IRF4 appears to have a prosurvival
effect on NLT CD11b+ DCs because the
remaining lung CD11b+ DCs lacking
IRF4 exhibited enhanced mitochondrial
fragmentation compared to WT cells.
This finding is in agreement with a study
reporting that IRF4-inhibited apoptosis
in myeloid cells (Shaffer et al., 2008).
The exact molecular mechanisms by
which IRF4 regulates mucosal CD11b+
DC survival remain to be investigated.
We could not identify similar IRF4-dependent CD11b+ DCs in
the dermis, kidney, or liver. CD24 and CD64 did not separate the
CD11b+ DC compartment and we did not detect any IRF4-
dependent CD11b+ DCs in both IRF4 mixed BM chimeras and
in mice lacking IRF4 in the DC lineage in these tissues. These
data suggest that IRF4-dependent CD11b+ DCs are specific to
the lung and the SI, suggesting the existence of a mucosal
CD11b+ DC lineage. This implies that CD11b+ DCs may not be
as homogeneous and conserved as the CD8a or CD103 lineage.
It remains to be ascertained if such mucosal specificity is
regulated at the tissue level by local conditioning of common
circulating DC progenitors or through a distinct lineage of
specific mucosal DC progenitors. Local microbiota present in
mucosal tissues could control IRF4 expression that in turn
promotes CD11b+ DC survival. However, we found no difference
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in the relative numbers of mucosal tissue CD11b+ DC com-
position, as well as IRF4 expression levels in germ-free mice
compared to control SPF mice (data not shown). Evidence for
a restricted progenitor potential was recently shown by BM
CCR9! pDC progenitors specifically giving rise to CD11c+
MCHII+CD11b+ cells in the lung upon adoptive transfer (Schlitzer
et al., 2012). A gut-tropic migratory DC precursor preferentially
giving rise to gut CD11b!CD103+ DCs was also recently
described (Zeng et al., 2012).
Migratory CD11b+ DCs are reduced in skin draining LNs of the
IRF4-deficient mice, whereas both CD11b+ and CD103+ DCs are
increased in the dermis of these mice (Bajan˜a et al., 2012). We
did not detect any major defect in the splenic or dermal DC
network of IRF4 mixed BM chimeras or in mice lacking IRF4 in
the DC lineage compared to the IRF4-deficient mice, suggesting
that either the IRF4 molecular mechanism of action is different in
these tissues or that an additional cell type is involved, which
confers the observed phenotype in the dermis (Bajan˜a et al.,
2012) and the spleen of the full IRF4-deficient mice (Suzuki
et al., 2004; Tamura et al., 2005). However, we observed defec-
tive migration of CD11b+ DCs in the skin draining LN, MLN, and
LLN. This observation suggests that IRF4, in addition to its spe-
cific role in the homeostasis of mucosal CD11b+ DCs, plays an
additional role in the migration of peripheral tissue CD11b+ DCs.
IL-23 is a crucial cytokine for the induction of Th17 cells at
mucosal sites such as the lung and the SI (Aggarwal et al.,
2003; Ahern et al., 2010). IL-23 at mucosal sites can be induced
by ligands derived from themicrobiota (Ivanov et al., 2009). How-
ever, the cell type responding to such exogenous cues in
mucosal tissues is ill understood. Previous data highlighted the
specific expression of IL-23 by a subset of SI-LP TLR5+CD11b+
DCs promoting Th17 T helper cells (Uematsu et al., 2008), and by
flagellin-stimulated CD11b+CD103+ DCs (Kinnebrew et al.,
2012). Another mouse model devoid of SI-LP CD11b+CD103+
DCs exhibited a reduced fraction of Th17 cells (Lewis et al.,
2011). This is also consistent with the recently reported capacity
of CD11b+CD103+ DCs to induce Th17 cell differentiation in vitro
(Denning et al., 2011). Moreover, clearance and protection of
asthma induced by A. fumigatus infection is mediated by TLR6
expression on CD11b+ DCs, which ultimately leads to secretion
of IL-23 and induction of protective Th17 immunity (Moreira
et al., 2011). In line with these reports, our data show that
CD11b+ DCs in the lung, as well as CD11b+CD103+ DCs in the
SI, express IL-23 during steady state and that their selective
loss leads to reduced IL-17A secreting CD4+ T cells and a
concomitant increase in IFN-g-producing T cells. Furthermore,
upon A. fumigatus infection in mice specifically lacking lung
CD11b+ DCs, Th17 T cells were reduced in numbers. However,
Th17 polarization may not be exclusive to IRF4-dependent
CD11b+ DCs, because we did not study the capacity of IRF4-in-
dependent CD11b+ DCs in other nonmucosal tissues and inflam-
matory DCs to promote Th17 immunity.
IRF4-dependent CD11b+ DCs may not only be specialized in
Th17 polarization. In our hands, IRF4-dependent CD11b+ DCs
did not contribute to Th1 polarization in a model of Influenza
infection because we found no difference in the relative numbers
of IFN-g-secreting CD4+ T cells between Itgax-cre Irf4fl/fl andWT
mice after Influenza challenge (data not shown). However, they
can contribute to Th2 polarization when challenged with the
adequate stimuli as shown recently in a model of low-dose
house dust mite allergen (Plantinga et al., 2013).
The separation of murine CD11b+ DCs from CD11b+ MACs
has now revealed the transcriptomic, phenotypic, and func-
tional similarities between human CD1c+ DCs and the bona
fide mouse CD11b+ DCs. Our previous transcriptomics
approach to align human and mouse DCs employed gene
signature generation for each DC subset followed by enrich-
ment analysis to interrogate signature similarities and differ-
ences between subsets. By using the same approach, we
found the lung CD24+CD11b+ DC gene signature to be related
to the human CD1c lineage, but the association was not statis-
tically significant. This was due to the modest signature list of
167 genes for the human CD1c+ DC lineage, and the lower
power of the nonparametric Kolmogorov-Smirnov test used
in the signature analysis (data not shown). However, by using
the predictions of our previous analysis that CD11b+ MACs
would be closer to CD14+ monocytes than CD1c+ DCs and
the converse relationship for CD11b+ DCs with CD1c+ DCs
rather than CD14+ monocytes, we were able to confirm the ho-
mology between CD11b+ DCs with CD1c+ DCs by analyzing
shared DEG between the two mouse and human subsets.
This strategy utilized a more powerful parametric (hypergeo-
metric) analysis to enhance statistical sensitivity to test this
hypothesis. We identified biologically significant genes shared
by mouse CD11b+ DCs and human CD1c+ DCs compared to
CD11b+ MACs and CD14+ monocytes respectively such as
Irf4, Ccr7, and the cell-cycle genes Cdh1 and Cdca71. The
homology identified between mouse CD11b+ DCs and human
CD1c+ DCs through transcriptomics was further substantiated
by phenotypic and functional similarities.
We found highest amount of IRF4 expression on human
CD1c+ DCs. Lung CD1c+ DCs also expressed significantly
higher levels of IL-23p19 transcript compared to CD141+ DCs,
but at a comparable level to CD14+ DCs. IL-23 production has
been described in monocyte and monocyte-related inflamma-
tory DCs (Plantinga et al., 2013; Segura et al., 2013) and is in
keeping with the close association of human CD14+ DCs to the
monocyte and/or macrophage lineage (Haniffa et al., 2012).
We also observed IL-23p19 and IL-12p70 coproduction by blood
CD1c+ DCs upon CL075 stimulation. IL-12p70 secretion was not
detected from human skin CD1c+ DCs (Haniffa et al., 2012) and
LP mononuclear cells (Dillon et al., 2010).
Nevertheless, both human lung and blood CD1c+ DCs pulsed
with A. fumigatus hyphae were superior at inducing IL-17A pro-
duction by autologous CD4+ T cells. The majority of Th17 cells
generated did not coproduce IFN-g or IL-22 (data not shown),
distinct to the IL-17 and IFN-g-producing Th17 cells observed
when naive CD4+ T cells were cultured with autologous mono-
cytes pulsed with C. albicans (Zielinski et al., 2012). A variety of
in vitro systems incorporating allogeneic and pathogen-induced
models have been utilized to study human Th17 differentiation
(Acosta-Rodriguez et al., 2007; Hansel et al., 2011). Blood
CD14+ monocytes and Slan+ DCs have been previously shown
to induce IL-17A-producing T helper cells in allogeneic models
(Acosta-Rodriguez et al., 2007; Hansel et al., 2011). It is therefore
possible that Th17 polarization is a specific function of, but not
exclusive to human IRF4-expressing CD1c+ DCs. This is sug-
gested by the reasonable capacity of CD14+ DCs to induce
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Th17 polarization ex vivo, although it remains to be proven
whether this subset migrates to the draining LN and is capable
of priming a naive response.
Finally, our observations advance the understanding of
the parallel organization of the mononuclear phagocyte sys-
tem in mouse and human mucosal tissues in steady state.
Both murine and human tissues contain resident SSChi
macrophages and two major DC subsets; mouse CD103+
DCs related to human CD141+ DCs with cross-presentation
abilities and mouse CD11b+ DCs, which we now show to
be related to human CD1c+ DCs with Th17 polarizing capabil-
ities. In addition, human tissues also contain CD14+ DCs with
monocyte and/or macrophage characteristics. The murine
counterpart of human CD14+ DCs is currently unknown. It is
tempting to speculate that the SSCloCD11b+CD64+CD14+
macrophage fraction we have characterized here (CD11b+
MACs) contains the functional equivalent of human CD14+
DCs, although this requires further validation. Functional align-
ment of mucosal mouse CD11b+ DCs and human CD1c+ DCs
will facilitate the translation of mouse in vivo findings to human
DC biology and aid the development of DC-based therapeutic
strategies.
EXPERIMENTAL PROCEDURES
Murine and Human Cell Suspension Preparation
Cell suspension from mouse organs and LN were prepared according to pub-
lished methods (Ginhoux et al., 2009; Bogunovic et al., 2009). Human samples
were obtained with informed consent in accordance with a favorable ethical
opinion from Newcastle, Munich, and Singapore Singhealth and National
Health Care Group Research Ethics Committees. PBMCs and lung DCs
were isolated as described previously (Haniffa et al., 2012). Colonic mucosa
was digested with Collagenase and DNase and passed through a 70 mm cell
strainer. Autologous CD4+ T cells were isolated from fresh blood by using
the RosetteSep human CD4+ T cell enrichment kit (StemCell Technologies).
Autologous naive CD4+ T cells were isolated by using the EasySep human
naive CD4+ T cell enrichment kit.
Infection Protocols
A. fumigatus (AF293, from ATCC) were cultivated for 5 days on Potato
dextrose agar (Sigma Aldrich, USA) and washed with PBS 0.05% Tween 20
to harvest A. fumigatus conidia. For infection, mice were anesthetized prior
to instillation of a suspension of 2 3 107 conidia/20 ml PBS intranasally (i.n.).
For infection in langerin-DTR mice, DT was administered intraperitoneally
(i.p.) at day !1 and day + 1 after live A. fumigatus conidia instillation and the
proportion of lung and lung LN CD3+CD4+ T expressing IFN-g or IL-17A was
measured at day 7. Mice were also monitored for fungal growth (CFU/organ,
mean ± SEM) by serially diluting homogenates and plating them in triplicate
on Sabouraud agar plates.
Microarray and Analysis
Total cellular RNA was extracted by using the mirVana! miRNA isolation
kit (Ambion Inc, Austin, TX, USA) for mouse samples and Trizol (Invitrogen,
Karlsbad, USA) for human samples and prepared for microarray
(Illumina Mouse WG6, Illumina Inc, San Diego, CA, USA) according to
manufacturer’s instructions. The human and mouse microarray expression
results were quantile normalized and summarized from probe level to
gene level by taking the mean expression across multiple probes mapping
to the same gene. Signatures were obtained in the human data set by
selecting genes that showed at least a 1.5-fold difference in mean ex-
pression between the blood CD1c+ DC and the blood CD14+ monocyte
samples. Similarly, the mouse signatures were obtained by using the same
methodology, but between lung CD11b+ DCs and lung CD11b+ MACs.
Details of transcriptomic analysis are available in Supplemental Experimental
Procedures.
T Cell Polarization Assay
FACS-sorted blood DCs were cultured at 5 3 104 cells/ml in 10% FCS IMDM
medium in a 96 well round-bottom plate. DCs were treated with A. fumigatus
hyphae (1 hyphae: 10 DCs) o/n. After o/n DC stimulation, 1 3 106/ml CD4+
T cells were added to DCs (1 DC: 20 T cells) or incubated alone ± stimuli.
On day 6, fresh media containing 10 U/mL IL-2 was added and cells were
transferred to a 96 well flat-bottom plate. On day 10, T cells were stimulated
with phorbol myristate acetate (PMA; 10ng/ml; Sigma-Aldrich) and ionomycin
(1 mg/ml; Sigma-Aldrich) for 4.5 hr in the presence of 10 mg/ml Brefeldin A
(10 mg/ml) after the first hour.
Statistical Analysis
Mann-Whitney, Kruskal Wallis, and unpaired t tests (with a 95% confidence)
were performed by using Prism 6.0 (GraphPad Software, La Jolla, USA). All
p values are two-tailed. *p < 0.05; **p < 0.01; and ***p < 0.001.
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(GEO) database (http://www.ncbi.nlm.nih.gov/gds) under the accession num-
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